$137,304,316
to UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
THE CENTER FOR ADVANCING POINT OF CARE IN HEART, LUNG, BLOOD AND SLEEP DISEASES
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds a research center developing point-of-care diagnostic technologies for heart, lung, blood, and sleep diseases.
Point-of-care diagnostics accelerate disease detection and treatment, reducing healthcare costs and improving patient outcomes in critical disease areas.
Drives demand for miniaturized diagnostic sensors, microfluidics, and portable medical device components from biotech suppliers.
Point-of-care diagnostics are strategic; China is advancing rapid-test capabilities, making U.S. innovation in this space competitively important.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002272.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_U54HL143541_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.